MEDIS Research Group Joined By OnkoDataMed, Focus On Oncology Trials
MEDIS RESEARCH GROUP, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists ONKODATAMED GmbH.
ONKODATAMED is a specialist provider of remote data capture solutions within a network of dermatologic, urologic and gynecologic oncologists. Through this network, MEDIS RESEARCH GROUP has now access to one of the largest epidemiological and clinical oncology databases in Europe containing information on thousands of patients currently in treatment – a valuable source for retrospective data analysis.
Dr Lutz Reimer, Managing Director of ONKODATAMED, says: ‘We are very happy to be joining MEDIS RESEARCH GROUP as one of the core members. The group’s clinical research services complement the portfolio of ONKODATAMED enabling us to jointly provide a wide range of services for the conduct of entire trial projects and retrospective data analysis. On the other hand, we can contribute to the group with our proven remote data capture software ODM QuaSi® as well as our large database of Urologic and Gynecologic Oncology patients.’
Michael Roehl, Managing Director of Allied Clinical Management, acknowledges:
Prof Dr Geerd Weyer, Founder and Managing Director of ICRC-Weyer, adds: ‘We can further perform cross-analyses of data parameters drawn from our network of oncology practices in Germany. As of January 2014, this network comprises over 220,000 patients undergoing hormone therapy for prostate carcinomas, over 135,000 Gynecologic Oncology patients as well as over 10,000 Uro-Oncology patients undergoing chemotherapy per year.’
Apart from the network of over 500 experienced dermatologic, urologic and gynecologic oncology practices in Germany, MEDIS RESEARCH GROUP has been performing site management and monitoring of phase Ib to III trials in over 20 leading university clinics specializing in colorectal, breast and pancreatic cancers in Germany, Austria and Switzerland, making the group a leading provider of clinical research services for prospective clinical trials, non-interventional and retrospective studies throughout the DACH region.
MEDIS RESEARCH GROUP will – for the first time in this constellation – introduce its consolidated services portfolio at the ICPM / DGPharMed Annual Conference in Berlin, 20-21 March 2014 as well as the DIA 26th Annual Euromeeting in Vienna, 25-27 March 2014. The group will be represented with a booth at each of these events.
About MEDIS RESEARCH GROUP:
MEDIS RESEARCH GROUP is a strategic partnership of three Berlin-Brandenburg based clinical research organizations:
In order to provide a single service point for their clients, the three members have developed and implemented guidelines to streamline their collaboration processes. This ensures that there is one contract with the client and one main contact person who will guide the client’s clinical trial project from commencement to its successful conclusion.
About the members:
ONKODATAMED GmbH was founded in 2003 and is located in Neuenhagen near Berlin. The ODM QuaSi® RDC system was originally developed to standardize retrospective trial documentation while assuring data quality for its network of experienced dermatologic, urologic and gynecologic oncologists. Since then, ODM has developed into a CRO providing all services relating non-interventional studies in outcome research, epidemiological cross-section studies and market and health services research. In particular, ODM has specialized in delivering data used in commission reports for the Joint Federal Committee (G-BA) to balance pharmaceutical innovation with affordability in Germany (AMNOG process).
ICRC-Weyer GmbH was founded in 1993 and has offices in Berlin-Friedrichshagen. The CRO’s core services are clinical data management, biostatistics and medical writing. Over the past few years, ICRC-Weyer, as a CDISC Gold Member, has developed special expertise in the standardization of clinical data bases and the analysis of clinical data. Further specialty areas include medical coding and expert medical data review as well as post market safety writing and value dossiers for German market entry.
Allied Clinical Management specializes in planning, managing and on-site monitoring of phase I to phase IV post-marketing clinical trials. ACM was founded in 2004 by Michael Roehl and has offices in downtown Berlin and near the internationally renowned Biotech Park in the northern district of Berlin-Buch. Allied Clinical Management is an audited member of German Federation of Contract Research Organizations (BVMA e.V. ) since 2009.